ASCO conference reports from the Citeline team: updates from Allogene Therapeutics Inc., AstraZeneca PLC, Daiichi Sankyo Co., Ltd., Servier, Merck & Co., Inc., Bicara Therapeutics , Roche Holding AG, Elevation Oncology, Inc., and ImmunoGen, Inc.
ASCO Round Up: Notable Presentations From Annual Cancer Conference
Citeline journalists report the top stories from the 2023 American Society of Clinical Oncology annual meeting, held in Chicago, US, 2-6 June.
More from Archive
More from In Vivo
• By
In Vivo Rising Leader Amir Hefni, CEO of Resolution Therapeutics, discusses the company's advancements in macrophage cell therapies for inflammatory and fibrotic diseases, and his transition from big pharma to biotech leadership.
• By
The sixth annual edition of In Vivo’s Rising Leaders features entrepreneurs, academics, lawyers, regulators and innovators from around the globe, representing the forefront of creativity in health care.
• By
Top 30 leaders: see the list of industry influencers highlighted in the sixth edition of In Vivo's Rising Leaders series.